Scientific article
OA Policy
English

Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions

Published inSwiss Medical Weekly, vol. 149, w14694
Publication date2019
Abstract

Direct-acting antiviral agents have revolutionised hepatitis C treatment. In 2014, the Swiss Hepatitis Strategy was developed to eliminate hepatitis C virus (HCV) infection and the associated liver-related morbidity and mortality by 2030. Though numerous national studies and assessments have identified a relatively low prevalence rate of 0.7% in the country, little has been done to identify the epidemiology of HCV on the regional, or micro, level. This study aimed to identify scenarios to achieve the objectives of Swiss Hepatitis Strategy by 2030 in eastern, western and northern regions in Switzerland.

Keywords
  • Hepatitis C virus
  • Liver cirrhosis
  • Hepatocellular
  • Carcinoma
  • Switzerland
Citation (ISO format)
RUSCH, Urs et al. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions. In: Swiss Medical Weekly, 2019, vol. 149, p. w14694. doi: 10.4414/smw.2019.14694
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1424-7860
366views
254downloads

Technical informations

Creation08/04/2019 16:06:00
First validation08/04/2019 16:06:00
Update time15/03/2023 16:26:04
Status update15/03/2023 16:26:03
Last indexation31/10/2024 13:23:52
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack